`
Monday, 26 June 2017

Japan News

  • Nipro strengthens US business with Infraredx acquisition

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015

    Tokyo: Nipro Corporation, headquartered in Osaka, Japan, has signed a definitive agreement to acquire US headquartered Infraredx Inc., an intravascular imaging company committed to advanci...Read more

  • Eisai, Purdue to co-develop insomnia drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2015

    Singapore: The US arm of Japan's Eisai has entered into a worldwide collaboration with Purdue Pharma to develop and commercialize Eisai's clinical candidate lemborexant, a dual orexin recep...Read more

  • Investment arm of Dentsu invests in Cue's at-home health tracker

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 30 Dec, 2015

    Tokyo-headquartered Dentsu Inc announced that the company's corporate venture capital arm Dentsu Ventures Global Fund has made an investment in Cue Inc. Cue Inc is a US technology company ...Read more

  • Eisai seeks simultaneous approval for anticancer agent in Japan, US and Europe

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015

    Japanese pharmaceutical major Eisai Co. Ltd. has submitted applications to regulatory authorities in Japan, United States and Europe (MHLW, FDA and EMA respectively) seeking an additional i...Read more

  • Astellas, ClearPath to enter strategic partnership

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2014

    Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious dis...Read more

  • Eisai publishes phase III results of anti-seizure drug

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2012

    Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304' online in the July 25, 2012, edition of Neurology...Read more

  • FDA approves Eisai's gastro reflux drug

    Japan |  Regulatory | By BioSpectrum Bureau | 0 Comment | 27 Mar, 2013

    Singapore: US FDA approved Eisai's Aciphex Sprinkle delayed-release capsules 5mg and 10mg for the treatment of gastroesophageal reflux disease (GERD) in children aged from one-to-11 years o...Read more

  • Asia an emerging hotspot in medical tourism

    Japan |  Analysis | By Aishwarya Venkatesh | 0 Comment | 09 Mar, 2015

    Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism.  Medical tourism industry is growing worldwide. Frost and Sullivan predicts that t...Read more

  • GSK receives marketing authorization for Nucala in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 30 Mar, 2016

    Singapore: GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for Nucala (mepolizumab) as a treatment for bronchial ast...Read more

  • Taiho licenses oral anticancer drug to France's Servier

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 16 Jun, 2015

    Japan's Taiho Pharmaceutical Co. Ltd. and France's Servier have entered into an exclusive license agreement on June 12, 2015 for the development and commercialization of TAS-102 (nonproprie...Read more

  • Daiichi, UCB seek marketing authorization for epilepsy drug in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2015

    Japanese pharmaceutical firms, Daiichi Sankyo Company Limited and UCB Japan Co. Ltd have announced that UCB Japan has applied for marketing authorization for lacosamide in Japan as adjuncti...Read more

  • PeptiDream, Teijin to co-discover peptide-based therapeutics

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015

    Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization collaboration agreement with Teijin Pharma Limited, Tokyo, Japan. The ...Read more

  • Japan's Denka group to acquire German biopharma business

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2015

    Singapore: Japan's Denki Kagaku Kogyo Kabushiki Kaisha (Denka Group) recently inked a pact to acquire Germany's Icon Genetics GmbH, a wholly owned company of Nomad Bioscience GmbH. Denka Gr...Read more

  • Ono, Bristol-Myers launch Orencia Auto-injector for treatment of Rheumatoid Arthritis

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 25 May, 2016

    Osaka-headquartered Ono Pharmaceutical Co Ltd and Bristol-Myers Squibb K K have launched Orencia Subcutaneous Injection 125 mg Auto-injector 1 mL (abatacept: genetically recombinant) for th...Read more

  • WuXi's subsidiary gets manufacturing nod in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2015

    Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical has received its first approval from the Japan PMDA for the ma...Read more

  • Mednet, Biovisiq deal helps in zero-delay of trials

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2013

    Singapore: AG Mednet signed a master services agreement with Biovisiq, a Japanese imaging core laboratory (ICL), to reduce image-related query stoppages in clinical trials, which can delay ...Read more

  • Singulex's cardiovascular biomarker granted Japanese patent

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2015

    Singulex Inc., California-based developer and provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, announced that the Japanese Patent Office ha...Read more

  • Chugai Pharma to set up sales unit in China

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2013

    Singapore: With a capital of $30 million, Tokyo based Chugai Pharmaceutical has announced to establish a wholly owned drug import and sales unit in China in March. The company said that Ch...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls